I think that is a stretch...they have made the company as lean as possible, renegotiated the site lease saving thousands of dollars, have abiomed as a key customer with a swelling order book. Your still getting emotional. The company clearly stated that if Nanodx turned into a commercial agreement they would update the market. It didn't and due to constant harassment by holders decided to clear the air. We move onto the quarterly in 3 weeks time with the company well placed. Abiomed by the looks of it will easily replace Nanodx for the company by the initial feedback for their product. Take a breath see what the quarterly brings and jump back in....
SE1 Price at posting:
2.4¢ Sentiment: Hold Disclosure: Held